Actively Recruiting
Improving Diagnosis of Pneumocystis in Adults with Weakened Immune Systems Using Non-Invasive Tests
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-04-23
240
Participants Needed
4
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating new diagnostic methods using quantitative polymerase chain reaction qPCR on non-invasive samples compared to reference techniques to diagnose pneumocystis PcP in immunocompromised adult patients suspected of having the infection. This observational study aims to improve the accuracy of PcP diagnosis to help guide patient care. The study is sponsored by Assistance Publique - Hf4pitaux de Paris and includes adult patients with suspected pneumocystis infection. Participants will provide biological samples including mouthwash, nasopharyngeal swabs, and blood samples. The study does not involve treatment but focuses on collecting these samples at the time of inclusion to compare fungal loads detected by qPCR and serum PCR, as well as beta D glucan blood levels. Patients are included if they have an indication for bronchial fibroscopy for bronchoalveolar lavage BAL or induced sputum. During the study, researchers will measure the Pearson correlation coefficient at inclusion to assess diagnostic agreement. They will also monitor fungal load and beta D glucan levels. Participation involves sample collection and clinical evaluation at the time of inclusion. The study is observational and includes healthy volunteers. The study period runs from July 8, 2025, to July 8, 2027.
CONDITIONS
Brief Title
Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients
Research Team
A
Agathe Vigouroux, MD
J
Jérôme Lambert, MD PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here